The effectiveness of using respiratory probiotic Streptococcus salivarius K12 in children with recurrent tonsillitis

Recurrent tonsillitis is common in all age groups, but the highest incidence is observed in the pediatric population due to morphological immaturity of the tonsils and age-related incompleteness of the immunological functions of the child’s body. The most promising direction in the therapy of recurrent tonsillitis today is the use of oral probiotics that inhibit Streptococcus pyogenes, one of the most significant pathogens in the oral cavity. The study showed that the use of Streptococcus salivarius K12 (Bactoblis) in the comprehensive therapy of recurrent tonsillitis for 30 days was characterized by a rapid relief of both local and general manifestations of disease, as well as a significant improvement in the microbiome of the upper respiratory tract. The results obtained indicate the possibility of using Streptococcus salivarius K12 for the prevention of relapse of recurrent tonsillitis and reduction of the incidence of local and general post-streptococcal complications in this category of patients.